Results 71 to 80 of about 20,052 (177)

Response to therapy and prognosis according to molecular characterization in <i>CALR</i>-mutated essential thrombocythemia. [PDF]

Hemasphere
Santaliestra M, Garrote M, Fernández-Rodríguez MC, Vélez P, Senín A, Arellano-Rodrigo E, Garcia-Gisbert N, Longarón R, Pérez-Encinas M, Caballero-Navarro G, Noya-Pereira MS, Cuevas B, Gómez-Casares MT, Stuckey R, Carreño-Tarragona G, Ferrer-Marin F, Cortés MA, Magro E, Mata I, Angona A, Pérez R, Fox ML, Pastor-Galán I, Sastre P, Triguero A, García-Gutierrez V, Hernández-Boluda JC, Bellosillo B, Alvarez-Larran A.   +28 more
europepmc   +1 more source

Acute STEMI in a young adult without conventional risk factors: a case report of JAK2-positive essential thrombocythemia. [PDF]

Eur Heart J Case Rep
Chen DM, Shin ED, Lee E, Xu L, Enders CL.   +4 more
europepmc   +1 more source

Evidence of jak2 val617phe positive essential thrombocythemia with splanchnic thrombosis during estroprogestinic treatment [PDF]

, 2008
Colagrande, M, Di Ianni,M, Lapecorella, M, Lucchesi,A, Mariani, G., NAPOLITANO, Mariasanta, Tabilio, A   +6 more
core  

Delayed Splenial Artery Pseudoaneurysm After Angiographically Negative Intracerebral Hemorrhage: A Case Report. [PDF]

Cureus
Ueda K, Mitsutake T, Kadooka K, Tanaka M.   +3 more
europepmc   +1 more source

Essential Thrombocythemia

Siriraj Medical Journal, 2002
This is a review of twelve cases of Essential Thrombocythemia at Suratthani Hospital, aged between 48 to 87 years old, 6 male and 6 female. The initial clinical presentations were as follows: 2 asymptomatic cases (incidentally found on routine CBC check up), 4 cases of cerebral infarction (one of them presented with paresthesia, erythromelalgia ...
openaire   +1 more source

DARS expression in JAK2V617F-positive myeloproliferative neoplasms: immunohistochemical analysis and clinical associations. [PDF]

Ann Hematol
Arafat AMA, Ghaffar HAA, Khallaf AM, Younes SAM, Morad MA, Mahgoub SMA.   +5 more
europepmc   +1 more source

4G/5G polymorphism and plasma levels of plasminogen activator inhibitor-1 in essential thrombocythemia patients with driver mutational status. [PDF]

Thromb J
Zhang X, Guo X.
europepmc   +1 more source

Prefibrotic myelofibrosis: recent updates in diagnosis, prognostication, and management 2026. [PDF]

Ther Adv Hematol
Al-Zubaidi N, Makris K, Sriskandarajah P.   +2 more
europepmc   +1 more source

Myelodysplastic syndrome and secondary acute leukemia after treatment of essential thrombocythemia with hydroxyurea [PDF]

, 1990
Anker-Lugtenburg, P.J. (P.) van den, Sizoo, W.   +1 more
core   +2 more sources

Symptom severity clusters in myeloproliferative neoplasms are unrelated to disease phenotype: results from a multicenter survey of the East German study group for hematology and oncology (OSHO #97). [PDF]

Front Oncol
Felser S, Koeppel M, Kuehl R, le Coutre P, Al-Ali HK, Schulze S, Muegge LO, Bormann J, Geissler J, Dadgar A, Junghanss C, Ulbricht S.   +11 more
europepmc   +1 more source